Koyfin Home > Directory > Health Care > Albireo Pharma Inc

Albireo Pharma Inc Price Chart ALBO

Historical daily share price chart and data for Albireo Pharma Inc since 2007 adjusted for splits and dividends. The latest closing price for Albireo Pharma Inc as of September 22, 2020 is $36.01.
  • In 2020 the stock opened at $25.73 and closed at $36.01 for a gain of 29% YTD.
  • In 2019 the stock opened at $24.24 and closed at $25.42 for a gain of 5%.
  • In 2018 the stock opened at $25.87 and closed at $24.53 for a loss of -5%.
  • In 2017 the stock opened at $18.17 and closed at $25.60 for a gain of 29%.
View Chart On Koyfin

Albireo Pharma Inc Summary

Stock Symbol: ALBO

Albireo Pharma Inc Company Info

Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal disorders. Its lead product candidate is odevixibat, an ileal bile acid transporter (IBAT) inhibitor that is in phase III clinical trial for treating patients with progressive familial intrahepatic cholestasis, as well as for treating biliary atresia, alagille syndrome, and other cholestatic liver diseases. The company is also developing Elobixibat for the treatment of chronic constipation and other functional diseases, and nonalcoholic steatohepatitis; and A3384 for the treatment of gastrointestinal diseases. It has a license agreement with EA Pharma for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.
Market Cap
683.9m
Dividend Yield
0 %
Beta vs SPX
1.23
Short Interest
144.3 %
30D Volatility
117.21
Hedge Fund Held
0 %
Competitors

Last 10 Days of ALBO Prices

09/22/2020$36.01
09/21/2020$37.62
09/18/2020$38.90
09/17/2020$39.05
09/16/2020$39.84
09/15/2020$39.75
09/14/2020$39.98
09/11/2020$38.48
09/10/2020$40.00
09/09/2020$41.61